In pancreatic ductal adenocarcinoma, IL-17A promotes tumor progression by inducing the differentiation of cancer-associated fibroblasts via IL-17RA and TNF signaling, creating a tumor-promoting stromal environment. Here, IL17A is linked to neoplasm.